Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Human Molecular Genetics

• Publication date

  2004-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDH147PMID 15128700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure.

  2004cited by this paper
• Angiotensin II and Cell Cycle Regulation

  2004cited by this paper
• Effect of Reduced Angiotensin-Converting Enzyme Gene Expression and Angiotensin-Converting Enzyme Inhibition on Angiotensin and Bradykinin Peptide Levels in Mice

  2004cited by this paper
• Down-regulation of bradykinin B2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat.

  2003cited by this paper
• Species-specific splicing and expression of angiotensin converting enzyme.

  2003cited by this paper
• The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes.

  2003cited by this paper
• Role of bradykinin in angiotensin-converting enzyme knockout mice.

  2003cited by this paper
• Important Role of Nitric Oxide in the Effect of Angiotensin-Converting Enzyme Inhibitor Imidapril on Vascular Injury

  2003cited by this paper
• Angiotensinogen Gene Haplotype and Hypertension: Interaction With ACE Gene I Allele

  2003cited by this paper
• Genetic Polymorphisms in the Renin‐Angiotensin System in High‐Altitude and Low‐Altitude Native American Populations

  2003cited by this paper
• Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis

  2002cited by this paper
• Rapid increase in cardiac adrenomedullin gene expression caused by acute pressure overload: effect of the renin-angiotensin system on gene expression.

  2002cited by this paper
• Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats.

  2002cited by this paper
• Angiotensin II infusion to the midgestation ovine fetus: effects on the fetal kidney.

  2000cited by this paper
• Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats.

  1999cited by this paper
• Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women.

  1998cited by this paper
• Down‐regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen‐2) 27 rats

  1997cited by this paper
• Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training.

  1997cited by this paper
• Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.

  1997cited by this paper
• Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.

  1997cited by this paper
• Angiotensin and bradykinin peptides in rats with myocardial infarction.

  1997cited by this paper
• Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects.

  1997cited by this paper
• Dissociation of left ventricular hypertrophy, beta-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis.

  1997cited by this paper
• Increased angiotensin-converting enzyme activity in the left ventricle after infarction.

  1997cited by this paper
• Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension.

  1996cited by this paper
• Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.

  1996cited by this paper
• Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies

  1996cited by this paper
• Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.

  1996cited by this paper
• Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.

  1996cited by this paper
• Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats.

  1995cited by this paper
• A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

  1995cited by this paper
• Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.

  1995cited by this paper
• Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.

  1995cited by this paper
• Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy.

  1995cited by this paper
• Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats.

  1995cited by this paper
• Regulation of ACE gene expression and plasma levels during rat postnatal development.

  1994cited by this paper
• Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

  1994cited by this paper
• Pharmacologic treatment of heart failure with standard drugs.

  1994cited by this paper
• Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.

  1994cited by this paper
• Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts.

  1994cited by this paper
• DD Genotype of the Angiotensin‐Converting Enzyme Gene Is a Risk Factor for Left Ventricular Hypertrophy

  1994cited by this paper
• Transgenic rats: new experimental models for the study of candidate genes in hypertension research.

  1994cited by this paper
• Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

  1994cited by this paper
• Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat.

  1994cited by this paper
• The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele.

  1994cited by this paper
• On the plasticity of the cerebellar renin-angiotensin system: localization of components and effects of mechanical perturbation.

  1994cited by this paper
• Activation of the renin-angiotensin system in heart failure and hypertrophy--studies in human hearts and transgenic rats.

  1994cited by this paper
• Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic mice.

  1993cited by this paper
• Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.

  1993cited by this paper
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

  1992cited by this paper
• The Molecular Basis of Cardiovascular Hypertrophy: The Role of the Renin‐Angiotensin System

  1992cited by this paper
• Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats.

  1991cited by this paper
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

  1990cited by this paper
• Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.

  1990cited by this paper
• Clinical implications for therapy: possible cardioprotective effects of ACE inhibition.

  1989cited by this paper
• Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.

  1989cited by this paper
• Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.

  1989cited by this paper
• Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

  1988cited by this paper

• Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2

  2020cites this paper
• Down-regulated RGS5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease.

  2019cites this paper
• Genome-Wide Association and Functional Studies Identify SCML4 and THSD7A as Novel Susceptibility Genes for Coronary Artery Disease

  2018cites this paper
• Down-Regulation of EPAS1 Transcription and Genetic Adaptation of Tibetans to High-Altitude Hypoxia

  2017influential citation
• TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and Caucasians.

  2016cites this paper
• Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney disease.

  2015cites this paper
• Clinical Relevance of Local Renin Angiotensin Systems

  2014cites this paper
• Molecular imaging of human ACE-1 expression in transgenic rats.

  2012cites this paper
• Corticosteroid hormone action in the cardiovascular system

  2011cites this paper
• Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 are involved in sinoaortic denervation-induced cardiovascular hypertrophy in rats.

  2011cites this paper
• Ace gene dosage influences the development of renovascular hypertension

  2010cites this paper
• Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy.

  2010cites this paper
• Cuff-induced vascular intima thickening is influenced by titration of the Ace gene in mice.

  2009cites this paper
• The role of renin-angiotensin-aldosterone system (RAAS) genes in the development of hypertrophy in hypertrophic cardiomyopathy (HCM)

  2009cites this paper
• GENETIC MODELS PROVIDE UNIQUE INSIGHT INTO ANGIOTENSIN AND BRADYKININ PEPTIDES IN THE EXTRAVASCULAR COMPARTMENT OF THE HEART IN VIVO

  2009cites this paper
• Promoter Polymorphisms in ACE (Angiotensin I–Converting Enzyme) Associated With Clinical Outcomes in Hypertension

  2009cites this paper
• The ontogeny of genes related to ovine fetal cardiac growth.

  2009cites this paper
• Differential ACE expression among tissues in allele-specific Wistar rat lines

  2009cites this paper
• Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks.

  2008cites this paper
• Mice expressing ACE only in the heart show that increased cardiac angiotensin II is not associated with cardiac hypertrophy.

  2008cites this paper
• Update on tissue renin–angiotensin systems

  2008cites this paper
• ANGIOTENSIN CONVERTING ENZYME GENOTYPE IN WISTAR RATS

  2007cites this paper
• Towards an integrated approach on RAAS-blockade

  2007cites this paper
• The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.

  2007cites this paper
• The role and regulation of cardiac angiotensin-converting enzyme for noninvasive molecular imaging in heart failure

  2007cites this paper
• Generation of transgenic mice for cardiovascular research.

  2006cites this paper
• ACE gene dosage modulates pressure-induced cardiac hypertrophy in mice and men.

  2006cites this paper
• Physiology of local renin-angiotensin systems.

  2006cites this paper
• hypertrophy in mice and men ACE gene dosage modulates pressure-induced cardiac

  2006cites this paper
• Increased maternal cortisol in late-gestation ewes decreases fetal cardiac expression of 11beta-HSD2 mRNA and the ratio of AT1 to AT2 receptor mRNA.

  2006cites this paper
• Regulation of components of the brain and cardiac renin-angiotensin systems by 17beta-estradiol after myocardial infarction in female rats.

  2006cites this paper
• Impact of genomics on research in the rat.

  2005cites this paper
• Overexpression of proadrenomedullin N‐terminal 20 peptide blunts blood pressure rise and attenuates myocardial hypertrophy and fibrosis in hypertensive rats

  2005cites this paper
• Impact of genomics on research in the rat

  2005cites this paper
• Transgenic Modifications of the Rat Genome

  2005cites this paper
• The kallikrein-kinin system: current and future pharmacological targets.

  2005cites this paper
• Increased Myocardial Collagen Content in Transgenic Rats Overexpressing Cardiac Angiotensin-Converting Enzyme Is Related to Enhanced Breakdown of N-Acetyl-Ser-Asp-Lys-Pro and Increased Phosphorylation of Smad2/3

  2004cites this paper
• Role of intravascular ultrasound in the evaluation of therapeutic interventions in coronary atherosclerosis Related review: Role of CETP inhibitors in the treatment of dyslipidemia (pp 631–636)

  2004cites this paper